Elk Grove Village, IL1 Active Studies

Parkinsons Disease Clinical Trials in Elk Grove Village, IL

Find 1 actively recruiting parkinsons disease clinical trials in Elk Grove Village, IL. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
120
Enrolling

Recruiting Parkinsons Disease Studies in Elk Grove Village

About Parkinsons Disease Clinical Trials in Elk Grove Village

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 1 parkinsons disease clinical trials recruiting participants in Elk Grove Village, IL. These studies are seeking a combined 120 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Elk Grove Village — FAQ

Are there parkinsons disease clinical trials in Elk Grove Village?

Yes, there are 1 parkinsons disease clinical trials currently recruiting in Elk Grove Village, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Elk Grove Village?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Elk Grove Village research site will contact you about next steps.

Are clinical trials in Elk Grove Village free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Elk Grove Village studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 1 active trials in Elk Grove Village are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov